Structure Evolution of Curcumin Nanoprecipitation from a Micromixer

被引:52
作者
He, Yi [1 ]
Huang, Yanbin [1 ]
Cheng, Yi [1 ]
机构
[1] Tsinghua Univ, Dept Chem Engn, Beijing 100084, Peoples R China
基金
中国国家自然科学基金;
关键词
PRECIPITATION; NANOPARTICLES;
D O I
10.1021/cg9009916
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Drug nanocrystal has become an important technology for poorly water-soluble drug delivery,and it is highly desirable to understand their formation mechanism and structure evolution pathway. Here we used curcumin as the model drug and studied in detail its nanoprecipitate structure evolution from a micromixer. Curcumin initially precipitated out as amorphous nanospheres, and then went through amorphous aggregation before transforming into needle-shaped crystals. The results clearly show a nonclassical crystallization pathway for curcumin nanoprecipitation.
引用
收藏
页码:1021 / 1024
页数:4
相关论文
共 22 条
[1]   Preparation of hydrocortisone nanosuspension through a bottom-up nanoprecipitation technique using microfluidic reactors [J].
Ali, Hany S. M. ;
York, Peter ;
Blagden, Nicholas .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2009, 375 (1-2) :107-113
[2]   Bioavailability of curcumin: Problems and promises [J].
Anand, Preetha ;
Kunnumakkara, Ajaikumar B. ;
Newman, Robert A. ;
Aggarwal, Bharat B. .
MOLECULAR PHARMACEUTICS, 2007, 4 (06) :807-818
[3]  
ARCOUMANIS C, 1990, EXP FLUIDS, V10, P177
[4]  
Colfen H., 2008, MESOCRYSTALS NONCLAS
[5]   Curcumin as "Curecumin":: From kitchen to clinic [J].
Goel, Ajay ;
Kunnumakkara, Ajaikumar B. ;
Aggarwal, Bharat B. .
BIOCHEMICAL PHARMACOLOGY, 2008, 75 (04) :787-809
[6]   Precipitation of nanoparticles in a T-mixer: Coupling the particle population dynamics with hydrodynamics through direct numerical simulation [J].
Gradl, Johannes ;
Schwarzer, Hans-Christoph ;
Schwertfirm, Florian ;
Manhart, Michael ;
Peukert, Wolfgang .
CHEMICAL ENGINEERING AND PROCESSING-PROCESS INTENSIFICATION, 2006, 45 (10) :908-916
[7]   Early stages of particle formation in precipitation reactions - quinacridone and boehmite as generic examples [J].
Haberkorn, H ;
Franke, D ;
Frechen, T ;
Goesele, W ;
Rieger, J .
JOURNAL OF COLLOID AND INTERFACE SCIENCE, 2003, 259 (01) :112-126
[8]   What is the true solubility advantage for amorphous pharmaceuticals? [J].
Hancock, BC ;
Parks, M .
PHARMACEUTICAL RESEARCH, 2000, 17 (04) :397-404
[9]   Experimental investigation of liquid-liquid mixing in T-shaped micro-mixers using μ-LIF and μ-PIV [J].
Hoffmann, M ;
Schlüter, M ;
Räbiger, N .
CHEMICAL ENGINEERING SCIENCE, 2006, 61 (09) :2968-2976
[10]  
Horn D, 2001, ANGEW CHEM INT EDIT, V40, P4331